Potential Pulmonary Uptake and Clearance of Morphine in Postoperative Patients
Overview
Authors
Affiliations
The influence of lung uptake and lung clearance on the disposition of morphine was studied in surgical patients. In the postoperative period morphine was given intravenously by a two-rate infusion regimen. Under steady-state conditions samples of mixed central venous blood (pulmonary artery) and peripheral arterial blood (radial artery) were taken simultaneously and at the same time cardiac output was measured. The concentration differences between venous and arterial blood were used to calculate the extraction ratio of morphine across the lung. In all patients there was marked pulmonary uptake, but the concentration differences in most of them were small under steady-state conditions. The extraction ratio (mean +/- SD) across the lung was 0.06 +/- 0.10, implying insignificant lung clearance. However, in two patients, both with diabetes mellitus, there was a significant concentration gradient, indicating that the lung could contribute to the total body elimination of morphine. On the other hand, the total clearance was similar in diabetic and nondiabetic patients (1190 and 1150 ml/min, respectively), implying that pulmonary clearance would have no significant influence on the kinetics of morphine. A physiologically based pharmacokinetic model was used to describe the disposition of morphine in post-operative patients. The model allowed simulation of pulmonary diffusion, uptake and elimination and supported conclusions based on model-independent experimental data.
Pulmonary disposition of pethidine in postoperative patients.
Persson M, Hartvig P, Wiklund L, PAALZOW L Br J Clin Pharmacol. 1988; 25(2):235-41.
PMID: 3358885 PMC: 1386479. DOI: 10.1111/j.1365-2125.1988.tb03296.x.
The altered pharmacokinetics and pharmacodynamics of drugs commonly used in critically ill patients.
Bodenham A, Shelly M, Park G Clin Pharmacokinet. 1988; 14(6):347-73.
PMID: 3293870 DOI: 10.2165/00003088-198814060-00003.
Hoskin P, Hanks G, Aherne G, Chapman D, Littleton P, Filshie J Br J Clin Pharmacol. 1989; 27(4):499-505.
PMID: 2719903 PMC: 1379730. DOI: 10.1111/j.1365-2125.1989.tb05399.x.
The effect of respiratory disorders on clinical pharmacokinetic variables.
Taburet A, Tollier C, Richard C Clin Pharmacokinet. 1990; 19(6):462-90.
PMID: 2292169 DOI: 10.2165/00003088-199019060-00004.
Milne R, Nation R, Somogyi A, Bochner F, Griggs W Br J Clin Pharmacol. 1992; 34(1):53-9.
PMID: 1633068 PMC: 1381375. DOI: 10.1111/j.1365-2125.1992.tb04107.x.